MCE - Delayed Quote EUR

Clínica Baviera, S.A. (CBAV.MC)

Compare
33.10
+0.10
+(0.30%)
At close: 5:35:22 PM GMT+1
Loading Chart for CBAV.MC
DELL
  • Previous Close 33.00
  • Open 33.60
  • Bid 33.10 x --
  • Ask 33.50 x --
  • Day's Range 32.70 - 33.60
  • 52 Week Range 23.00 - 39.50
  • Volume 1,782
  • Avg. Volume 2,672
  • Market Cap (intraday) 529.14M
  • Beta (5Y Monthly) 0.68
  • PE Ratio (TTM) 14.33
  • EPS (TTM) 2.31
  • Earnings Date Feb 26, 2025 - Mar 3, 2025
  • Forward Dividend & Yield 1.57 (4.51%)
  • Ex-Dividend Date Jul 16, 2024
  • 1y Target Est --

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, and vías lagrimales treatments. The company is based in Madrid, Spain.

www.clinicabaviera.com

1,326

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CBAV.MC

View More

Performance Overview: CBAV.MC

Trailing total returns as of 1/7/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

CBAV.MC
6.09%
IBEX 35...
2.38%

1-Year Return

CBAV.MC
51.36%
IBEX 35...
16.21%

3-Year Return

CBAV.MC
61.49%
IBEX 35...
34.38%

5-Year Return

CBAV.MC
179.89%
IBEX 35...
23.03%

Compare To: CBAV.MC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CBAV.MC

View More

Valuation Measures

As of 1/6/2025
  • Market Cap

    527.54M

  • Enterprise Value

    556.78M

  • Trailing P/E

    14.28

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.11

  • Price/Book (mrq)

    6.30

  • Enterprise Value/Revenue

    2.22

  • Enterprise Value/EBITDA

    7.82

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.79%

  • Return on Assets (ttm)

    17.77%

  • Return on Equity (ttm)

    49.97%

  • Revenue (ttm)

    243.31M

  • Net Income Avi to Common (ttm)

    38.41M

  • Diluted EPS (ttm)

    2.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    49.38M

  • Total Debt/Equity (mrq)

    1.87%

  • Levered Free Cash Flow (ttm)

    61.55M

Research Analysis: CBAV.MC

View More

People Also Watch